Allergy Diagnostics and Therapeutics Market

Allergy Diagnostics and Therapeutics Market by Products (Instruments, Consumables, and Services), Allergen Types (Food, Inhaled, Drug, and Others), End Uses (Diagnostic Laboratories, Hospitals, and Academic Research Institutes), Diagnostic Tests (In vivo Test [Skin Prick Test, Intradermal Test, and Patch Test], and In vitro Test), Drug Classes (Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-1728
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 183
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global allergy diagnostics and therapeutics market size is projected to expand at a considerable CAGR during the forecast period, 2021–2028. The growth of the market is attributed to increasing allergic disease cases, as well as a significant requirement for in vitro diagnostic blood tests.

Allergy Diagnostics and Therapeutics Market key Takeaways

Allergy diagnostics refers to various types of tests that can be used to detect if a person is more likely to develop or has developed an allergy or allergies. On the other hand, therapeutics are the types of remediation that people take to avoid or decrease the effects of various types of health problems.

According to the World Health Organization (WHO), about 40 million cases of inhalation allergies were reported in the US in 2012. The enforced lockdowns and imposed limits by regulatory bodies in the wake of the recent COVID-19 outbreak, numerous industries' operations have either been temporarily halted or are operating with reduced personnel. The worldwide allergy diagnostics and therapeutics market is no exception, and this factor has negatively impacted the industry growth.

During the forecast period, the introduction of technologically enhanced diagnostic and therapeutic products that provide extremely sensitive and accurate results is expected to positively impact the global market. In 2018, the inhaled allergen type category held a prominent market share, and this trend is expected to continue in the projected timeline. This increase can be ascribed to rising number of people suffering from respiratory allergies. According to the data published by American Academy of Allergy Asthma and Immunology (AAAAI) in 2012, over 7.8 million children globally suffer from respiratory allergies.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing prevalence of allergic conditions coupled with adoption of immunoassay as diagnostic test is projected to drive the market growth during the forecast period.
  • Changing lifestyles, rising levels of indoor and outdoor pollution, poor eating habits, and rapid urbanization are contributing to the increase in allergic disease cases.
  • Rising greenhouse gas (GHG) concentrations is expected to increase the prevalence of pollen-induced respiratory disease, which is anticipated to spur the market expansion during the forecast period.
  • The introduction of technologically advanced products, such as the MeDALL allergen-chip for allergy detection is estimated to propel the market expansion in the coming years.

Scope of the Report

The report on the global allergy diagnostics and therapeutics market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Allergy Diagnostics and Therapeutics Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Products (Instruments, Consumables, and Services), Allergen Types (Food, Inhaled, Drug, and Others), End Uses (Diagnostic Laboratories, Hospitals, and Academic Research Institutes), Diagnostic Tests (In vivo Test
 [Skin Prick Test, Intradermal Test, and Patch Test], and In vitro Test), and Drug Classes (Antihistamines, Decongestants, Corticosteroids, Mast Cell Stabilizers, Leukotriene Inhibitors, Nasal Anticholinergics, Immunomodulators, Auto injectable Epinephrine, and Immunotherapy)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

bioMerieux, Thermo Fisher Scientific, Danaher Corporation, Omega Diagnostics, Hitachi Chemical Diagnostics, Stallergenes Greer, Siemens Healthcare, Lincoln Diagnostics, Hycor Biomedical, HOB Biotech Group, and Alcon Laboratories.

 

Allergy Diagnostics and Therapeutics Market Segment Insights

Consumables segment is projected to account for a key market share

Based on products, the market is divided into instruments, consumables, and services. The consumables segment is expected to account for a key share of the market during the forecast period owing to technological advancements, such as allergen microarray kits that are more sensitive and provide patients effective profiling and monitoring. Furthermore, the introduction of products such as MeDALL allergen-chip, which is associated with increased sensitivity specificity and faster diagnosis, is expected to support the market segment growth.

Allergy Diagnostics and Therapeutics Market by products

In vitro segment is expected to grow at a rapid pace

On the basis of diagnostic tests, the allergy diagnostics and therapeutics market is bifurcated into in vivo and in vitro test. The in vivo segment is further divided into skin prick test, intradermal test, and patch test. The skin prick sub-segment is expected to account for a key market share owing to to greater adoption of this test by healthcare professionals and patients. This is owing to the increasing use of skin prick tests for food allergy identification and specific IgE-mediated allergy testing. However, the in vitro segment is anticipated to expand at a rapid pace during the forecast period owing to growing demand for less invasive diagnostic methods, laboratory automation, and highly sensitive and accurate results. Companies are focusing on providing allergy-specific solutions and accurate result-oriented devices to expand their market share.

Inhaled segment is anticipated to register a substantial CAGR

In terms of allergen types, the market is segregated into food, inhaled, drug, and others. The inhaled segment is expected to account for a significant market share owing to increasing incidence of respiratory allergies and asthma across the globe. Rising demand for allergy testing and the introduction of specific allergens for allergy detection are expected to contribute to the high CAGR of this market segment. However, the drug segment is anticipated to expand at a rapid pace during the forecast period. In terms of revenue share, food segment accounted for second-largest market in 2020 and this trend is expected to continue in the projected timeline. This sort of allergy disorder is more common in children. Food allergies are twice as common in youngsters as they are in adults, according to figures published by the US National Institute of Health (NIH).

Hospital segment is expected to grow at a rapid pace

Based on end uses, the allergy diagnostics and therapeutics market is divided into diagnostic laboratories, hospitals, and academic research institutes. The diagnostic laboratories segment is expected to account for a considerable market share during the forecast period owing to the widespread use of immunoassay tests in allergy diagnosis. Ongoing advancements in screening techniques that allow accurate disease diagnosis and stratification for appropriate treatment are expected to drive the segment growth. However, the hospital segment is anticipated to expand at a rapid pace during the forecast period owing to the government support and rising investment in the healthcare infrastructure.

Allergy Diagnostics and Therapeutics Market by end uses

Immunotherapy segment is expected to grow at a rapid pace

On the basis of drug classes, the market is classified as antihistamines, decongestants, corticosteroids, mast cell stabilizers, leukotriene inhibitors, nasal anticholinergics, immunomodulators, auto injectable epinephrine, and immunotherapy. The immunotherapy segment is expected to account for a large market share during the forecast period owing to rising demand for sublingual vaccinations, a large medication pipeline, increasing number of clinical studies of monoclonal antibodies for the treatment of allergic diseases, and growing patient awareness. The antihistamines segment dominated the market share in 2018, owing to their numerous benefits and applications in the treatment of allergic illnesses. According to the American Academy of Allergy Asthma & Immunology (AAAAI), allergic rhinitis affects 10% to 30% of the global population, contributing to the adoption of allergy treatments.

Asia Pacific is expected to dominate the market

In terms of regions, the allergy diagnostics and therapeutics market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia Pacific is anticipated to expand at an impressive CAGR during the forecast period. The regional market growth is attributed to rapidly improving healthcare infrastructure, unmet clinical requirements, and increasing demand for minimally invasive diagnostic tools. In terms of revenue, North America led the global market in 2018 due to a high prevalence of respiratory allergic disorders, rising awareness of allergy diagnostics, and the adoption of in vitro blood tests. Factors such as presence of a developed pharmaceutical industry and rising demand for therapeutics are expected to help Europe to become a prominent market in the projected timeline. The regional market growth is attributed to growing geriatric population and increasing prevalence of allergic conditions.

Segments

Segments Covered in the Report
The global allergy diagnostics and therapeutics market has been segmented on the basis of

Products

  • Instruments
  • Consumables
  • Services

Allergen Types

  • Food
  • Inhaled
  • Drug
  • Other

End Uses

  • Diagnostic Laboratories
  • Hospitals
  • Academic Research Institutes

Diagnostic Tests

  • In vivo Test
    • Skin Prick Test
    • Intradermal Test
    • Patch Test
  • In vitro Test

Drug Classes

  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anticholinergics
  • Immunomodulators
  • Auto injectable Epinephrine
  • Immunotherapy

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • BioMerieux
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Omega Diagnostics
  • Hitachi Chemical Diagnostics
  • Stallergenes Greer
  • Siemens Healthcare
  • Lincoln Diagnostics
  • Hycor Biomedical
  • HOB Biotech Group
  • Alcon Laboratories

Competitive Landscape

Key players competing in the allergy diagnostics and therapeutics market include bioMerieux, Thermo Fisher Scientific, Danaher Corporation, Omega Diagnostics, Hitachi Chemical Diagnostics, Stallergenes Greer, Siemens Healthcare, Lincoln Diagnostics, Hycor Biomedical, HOB Biotech Group, and Alcon Laboratories.

Companies are actively involved in new product launches, strategic collaborations, acquisitions, and technological improvements to achieve maximum market share in a highly competitive market.

In October 2017, Stallergenes Greer purchased Medic Savoure Ltd., bolstering its position in the allergy immunotherapy industry in Canda. In July 2016, Novartis AG got FDA approval for the use of its medicine, Xolair, in the treatment of juvenile allergic asthma, which helped to broaden the company's product line.

Allergy Diagnostics and Therapeutics Market by Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Allergy Diagnostics and Therapeutics Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Allergy Diagnostics and Therapeutics Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Allergy Diagnostics and Therapeutics Market - Supply Chain
  4.5. Global Allergy Diagnostics and Therapeutics Market Forecast
     4.5.1. Allergy Diagnostics and Therapeutics Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Allergy Diagnostics and Therapeutics Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Allergy Diagnostics and Therapeutics Market Absolute $ Opportunity
5. Global Allergy Diagnostics and Therapeutics Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by End Users
     5.3.1. Diagnostic Laboratories
     5.3.2. Hospitals
     5.3.3. Academic Research Institutes
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Allergy Diagnostics and Therapeutics Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Allergy Diagnostics and Therapeutics Demand Share Forecast, 2019-2026
7. North America Allergy Diagnostics and Therapeutics Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by End Users
     7.4.1. Diagnostic Laboratories
     7.4.2. Hospitals
     7.4.3. Academic Research Institutes
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Allergy Diagnostics and Therapeutics Demand Share Forecast, 2019-2026
8. Latin America Allergy Diagnostics and Therapeutics Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by End Users
     8.4.1. Diagnostic Laboratories
     8.4.2. Hospitals
     8.4.3. Academic Research Institutes
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Allergy Diagnostics and Therapeutics Demand Share Forecast, 2019-2026
9. Europe Allergy Diagnostics and Therapeutics Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by End Users
     9.4.1. Diagnostic Laboratories
     9.4.2. Hospitals
     9.4.3. Academic Research Institutes
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Allergy Diagnostics and Therapeutics Demand Share Forecast, 2019-2026
10. Asia Pacific Allergy Diagnostics and Therapeutics Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by End Users
     10.4.1. Diagnostic Laboratories
     10.4.2. Hospitals
     10.4.3. Academic Research Institutes
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Allergy Diagnostics and Therapeutics Demand Share Forecast, 2019-2026
11. Middle East & Africa Allergy Diagnostics and Therapeutics Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Allergy Diagnostics and Therapeutics Market Size and Volume Forecast by End Users
     11.4.1. Diagnostic Laboratories
     11.4.2. Hospitals
     11.4.3. Academic Research Institutes
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Allergy Diagnostics and Therapeutics Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Allergy Diagnostics and Therapeutics Market: Market Share Analysis
  12.2. Allergy Diagnostics and Therapeutics Distributors and Customers
  12.3. Allergy Diagnostics and Therapeutics Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. BioMerieux
     12.4.2. Thermo Fisher Scientific
     12.4.3. Danaher Corporation
     12.4.4. Omega Diagnostics
     12.4.5. Hitachi Chemical Diagnostics
     12.4.6. Stallergenes Greer
     12.4.7. Siemens Healthcare

Segments Covered in the Report
The global allergy diagnostics and therapeutics market has been segmented on the basis of

Products

  • Instruments
  • Consumables
  • Services

Allergen Types

  • Food
  • Inhaled
  • Drug
  • Other

End Uses

  • Diagnostic Laboratories
  • Hospitals
  • Academic Research Institutes

Diagnostic Tests

  • In vivo Test
    • Skin Prick Test
    • Intradermal Test
    • Patch Test
  • In vitro Test

Drug Classes

  • Antihistamines
  • Decongestants
  • Corticosteroids
  • Mast Cell Stabilizers
  • Leukotriene Inhibitors
  • Nasal Anticholinergics
  • Immunomodulators
  • Auto injectable Epinephrine
  • Immunotherapy

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • BioMerieux
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Omega Diagnostics
  • Hitachi Chemical Diagnostics
  • Stallergenes Greer
  • Siemens Healthcare
  • Lincoln Diagnostics
  • Hycor Biomedical
  • HOB Biotech Group
  • Alcon Laboratories

Key players competing in the allergy diagnostics and therapeutics market include bioMerieux, Thermo Fisher Scientific, Danaher Corporation, Omega Diagnostics, Hitachi Chemical Diagnostics, Stallergenes Greer, Siemens Healthcare, Lincoln Diagnostics, Hycor Biomedical, HOB Biotech Group, and Alcon Laboratories.

Companies are actively involved in new product launches, strategic collaborations, acquisitions, and technological improvements to achieve maximum market share in a highly competitive market.

In October 2017, Stallergenes Greer purchased Medic Savoure Ltd., bolstering its position in the allergy immunotherapy industry in Canda. In July 2016, Novartis AG got FDA approval for the use of its medicine, Xolair, in the treatment of juvenile allergic asthma, which helped to broaden the company's product line.

Allergy Diagnostics and Therapeutics Market by Key Players

Buy Report